Skip to content
GLP-1 Desk
Menu
Dispatch #281

Signos

Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app — pairing the medication with…

Visit SignosAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$199/mo (6-month plan, compounded)
Tirzepatide
$199/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh Signos against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: Signos vs CoreAge Rx. Because Signos dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency68/100
State access24/100
Molecule range66/100
Onboarding speed72/100
Support responsiveness82/100
Licensing & trust78/100

What the Desk likes

  • Bundles compounded GLP-1 (semaglutide) with an FDA-cleared CGM and app — glucose-guided weight loss, not just medication
  • Starting at $199/mo on a 6-month program, with the CGM included at no extra cost
  • Free rapid shipping; HSA/FSA eligible
  • Real-time glucose insights and app coaching to help sustain results after GLP-1

Where points come off

  • Compounded GLP-1s are not FDA-approved finished products
  • Headline price is a 6-month-program rate, not month-to-month
  • Only semaglutide is shown in the program; tirzepatide availability is not confirmed
  • Compounding pharmacy partner and state availability are not published on the landing page

The Desk's briefing — C

Best for: Readers who want pairing compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor and app.

Signos ranks #281 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect Signos's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Signos's site. Not medical advice; see our disclosure.

← Back to The Desk